Literature DB >> 21233474

Cerebral microbleeds are predictive of mortality in the elderly.

Irmhild Altmann-Schneider1, Stella Trompet, Anton J M de Craen, Adriaan C G M van Es, J Wouter Jukema, David J Stott, Naveed Sattar, Rudi G J Westendorp, Mark A van Buchem, Jeroen van der Grond.   

Abstract

BACKGROUND AND
PURPOSE: To investigate the prognostic value of cerebral microbleeds (CMB) regarding overall, cardiovascular-related, and stroke-related mortality and to investigate possible differences based on a cerebral amyloid angiopathy-type and nonlobar distribution of microbleeds.
METHODS: We included 435 subjects who were participants from the nested MRI substudy of the PROspective Study of Pravastatin in the Elderly at Risk (PROSPER). Cox proportional hazard models were applied to estimate the risk of overall, cardiovascular-related, and stroke-related death associated with microbleeds in general and microbleeds with a lobar distribution suggestive of the presence of cerebral amyloid angiopathy. The corresponding Kaplan-Meier survival curves were calculated.
RESULTS: Subjects with >1 CMB had a 6-fold risk of stroke-related death compared to subjects without CMB (hazard ratio, 5.97; 95% CI, 1.60-22.26; P=0.01). The diagnosis of nonlobar microbleeds was associated with >2-fold risk of cardiovascular death compared to subjects without microbleeds (hazard ratio, 2.67; 95% CI, 1.23-5.81; P=0.01). Subjects with probable cerebral amyloid angiopathy-type microbleeds had >7-fold risk of stroke-related death compared to subjects without CMB (hazard ratio, 7.20; 95% CI, 1.44-36.10; P=0.02).
CONCLUSIONS: This is the first study investigating the association between microbleeds and risk of overall, cardiovascular-related, and stroke-related mortality in an elderly population. Our findings indicate that the diagnosis of microbleeds is potentially of clinical relevance. Larger studies are needed to expand our observations and to address potential clinical implications and cost-benefits of such a policy.

Entities:  

Mesh:

Year:  2011        PMID: 21233474     DOI: 10.1161/STROKEAHA.110.595611

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  29 in total

1.  Cerebral Microbleeds as Predictors of Mortality: The Framingham Heart Study.

Authors:  José R Romero; Sarah R Preis; Alexa Beiser; Jayandra J Himali; Ashkan Shoamanesh; Philip A Wolf; Carlos S Kase; Ramachandran S Vasan; Charles DeCarli; Sudha Seshadri
Journal:  Stroke       Date:  2017-01-31       Impact factor: 7.914

2.  Multidentate (18)F-polypegylated styrylpyridines as imaging agents for Aβ plaques in cerebral amyloid angiopathy (CAA).

Authors:  Zhihao Zha; Seok Rye Choi; Karl Ploessl; Brian P Lieberman; Wenchao Qu; Franz Hefti; Mark Mintun; Daniel Skovronsky; Hank F Kung
Journal:  J Med Chem       Date:  2011-11-09       Impact factor: 7.446

Review 3.  Cerebral microhemorrhages: mechanisms, consequences, and prevention.

Authors:  Zoltan Ungvari; Stefano Tarantini; Angelia C Kirkpatrick; Anna Csiszar; Calin I Prodan
Journal:  Am J Physiol Heart Circ Physiol       Date:  2017-03-17       Impact factor: 4.733

4.  Clinical Significance of Magnetic Resonance Imaging Markers of Vascular Brain Injury: A Systematic Review and Meta-analysis.

Authors:  Stéphanie Debette; Sabrina Schilling; Marie-Gabrielle Duperron; Susanna C Larsson; Hugh S Markus
Journal:  JAMA Neurol       Date:  2019-01-01       Impact factor: 18.302

5.  Risk Factors Associated With Incident Cerebral Microbleeds According to Location in Older People: The Age, Gene/Environment Susceptibility (AGES)-Reykjavik Study.

Authors:  Jie Ding; Sigurdur Sigurdsson; Melissa Garcia; Caroline L Phillips; Gudny Eiriksdottir; Vilmundur Gudnason; Mark A van Buchem; Lenore J Launer
Journal:  JAMA Neurol       Date:  2015-06       Impact factor: 18.302

6.  Cerebral microbleeds and the risk of mortality in the general population.

Authors:  Saloua Akoudad; Mohammad Arfan Ikram; Peter Jan Koudstaal; Albert Hofman; Aad van der Lugt; Meike Willemijn Vernooij
Journal:  Eur J Epidemiol       Date:  2013-09-26       Impact factor: 8.082

Review 7.  Dementia in 2011: Microbleeds in dementia--singing a different ARIA.

Authors:  Philip Scheltens; Jeroen D C Goos
Journal:  Nat Rev Neurol       Date:  2012-01-10       Impact factor: 42.937

8.  Microbleeds in the Secondary Prevention of Small Subcortical Strokes Trial: Stroke, mortality, and treatment interactions.

Authors:  Ashkan Shoamanesh; Lesly A Pearce; Carlos Bazan; Luciana Catanese; Leslie A McClure; Mukul Sharma; Joan Marti-Fabregas; David C Anderson; Carlos S Kase; Robert G Hart; Oscar R Benavente
Journal:  Ann Neurol       Date:  2017-07-19       Impact factor: 10.422

9.  Clinical significance of cerebral microbleeds on MRI: A comprehensive meta-analysis of risk of intracerebral hemorrhage, ischemic stroke, mortality, and dementia in cohort studies (v1).

Authors:  Andreas Charidimou; Sara Shams; Jose R Romero; Jie Ding; Roland Veltkamp; Solveig Horstmann; Gudny Eiriksdottir; Mark A van Buchem; Vilmundur Gudnason; Jayandra J Himali; M Edip Gurol; Anand Viswanathan; Toshio Imaizumi; Meike W Vernooij; Sudha Seshadri; Steven M Greenberg; Oscar R Benavente; Lenore J Launer; Ashkan Shoamanesh
Journal:  Int J Stroke       Date:  2018-01-17       Impact factor: 5.266

10.  Incidence of symptomatic hemorrhage in patients with lobar microbleeds.

Authors:  Ellis S van Etten; Eitan Auriel; Kellen E Haley; Alison M Ayres; Anastasia Vashkevich; Kristin M Schwab; Jonathan Rosand; Anand Viswanathan; Steven M Greenberg; M Edip Gurol
Journal:  Stroke       Date:  2014-06-19       Impact factor: 7.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.